Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry ®

Author:

Arnold Suzanne V.1,Goyal Abhinav2,Inzucchi Silvio E.3,McGuire Darren K.4,Tang Fengming1,Mehta Sanjeev N.5,Sperling Laurence S.2,Maddox Thomas M.6,Einhorn Daniel7,Wong Nathan D.8,Hammar Niklas9,Fenici Peter10,Khunti Kamlesh11,Lam Carolyn S. P.12,Kosiborod Mikhail1

Affiliation:

1. Saint Luke's Mid America Heart Institute and University of Missouri‐Kansas City, Kansas City, MO

2. Emory University School of Medicine, Atlanta, GA

3. Yale School of Medicine, New Haven, CT

4. University of Texas Southwestern Medical Center, Dallas, TX

5. Joslin Diabetes Center, Boston, MA

6. Washington University School of Medicine, Saint Louis, MO

7. University of California, San Diego School of Medicine, San Diego, CA

8. University of California, Irvine School of Medicine, Irvine, CA

9. AstraZeneca, Mölndal, Sweden

10. AstraZeneca, Rome, Italy

11. University of Leicester, England

12. Duke‐National University of Singapore and National Heart Centre, Singapore

Abstract

Background Although guidelines and performance measures exist for patients with diabetes mellitus, achievement of these metrics is not well known. The Diabetes Collaborative Registry ® (DCR) was formed to understand the quality of diabetes mellitus care across the primary and specialty care continuum in the United States. Methods and Results We assessed the frequency of achievement of 7 diabetes mellitus–related quality metrics and variability across the Diabetes Collaborative Registry ® sites. Among 574 972 patients with diabetes mellitus from 259 US practices, median (interquartile range) achievement of the quality metrics across the practices was the following: (1) glycemic control: 19% (5–47); (2) blood pressure control: 80% (67–88); (3) angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers in patients with coronary artery disease: 62% (51–69); (4) nephropathy screening: 62% (53–71); (5) eye examination: 0.7% (0.0–79); (6) foot examination: 0.0% (0.0–2.3); and (7) tobacco screening/cessation counseling: 86% (80–94). In hierarchical, modified Poisson regression models, there was substantial variability in meeting these metrics across sites, particularly with documentation of glycemic control and eye and foot examinations. There was also notable variation across specialties, with endocrinology practices performing better on glycemic control and diabetes mellitus foot examinations and cardiology practices succeeding more in blood pressure control and use of angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers. Conclusions The Diabetes Collaborative Registry ® was established to document and improve the quality of outpatient diabetes mellitus care. While target achievement of some metrics of cardiovascular risk modification was high, achievement of others was suboptimal and highly variable. This may be attributable to fragmentation of care, lack of ownership among various specialists concerning certain domains of care, incomplete documentation, true gaps in care, or a combination of these factors.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3